Keyword

IMvigor210

Description: IMvigor210 is a clinical study of atezolizumab treatment in patients with advanced or metastatic urothelial carcinoma.
OpenAlex ID: keywords/imvigor210
2020 · Sangeeta Goswami, Yulong Chen, et al. · Science Translational Medicine · 138
2020 · Ashley M. Hopkins, Ganessan Kichenadasse, et al. · European Urology · 114
2021 · Ahmad Y. Abuhelwa, Joaquim Bellmunt, et al. · Clinical Genitourinary Cancer · 31
2020 · Xianghong Zhou, Shi Qiu, et al. · Frontiers in Oncology · 31
2023 · Zenghong Wu, Weijun Wang, et al. · Biomolecules · 30
2022 · Rui Yang, Wengang Zhang, et al. · Frontiers in Pharmacology · 30
Works count: 241
Citation count: 3,700
Year
Topic
Type